Packaging & Labelling
UPS Healthcare Continues Global Facility Expansion To Meet Growing Demands In Key Markets
UPS announced a series of facility expansions to its healthcare-dedicated warehouse and distribution network in key global markets. This includes new GDP-compliant space opening in Central and Eastern Europe and additional cold chain space coming online near its UPS...
Clinical Trials
TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19
TrialSpark, a tech-enabled drug development company committed to improving the speed, quality, and innovation of clinical trials, announced the launch of Project Covalence, a turnkey trial platform that enables investigators and sponsors to rapidly launch clinical trials for COVID-19....
Press Releases
Agena Bioscience Announces EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, announced the launch of the iPLEX® Pro SARS-CoV-2 Panel for qualitative detection of the novel coronavirus that causes COVID-19. Clinical laboratories can process more than 6000...
Press Releases
Sanofi invests in vaccine research and production
Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks. Aligned with its corporate strategy presented last December, Sanofi will...
Press Releases
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
IDEAYA Biosciences, Inc. and GlaxoSmithKline plc announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology.
The strategic partnership includes IDEAYA’s Synthetic Lethality programs MAT2A, Pol Theta, and Werner Helicase programs, which are projected to reach clinical trials...
Press Releases
Pfizer Announced FDA Approval of Oncology Supportive Care Biosimilar, NYVEPRIA
Pfizer Inc. announced the US FDA has approved NYVEPRIA, a biosimilar to Neulasta NYVEPRIA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a...
Press Releases
Sunovion Announces Health Canada Approval of KYNMOBI Soluble Film for the Treatment of Parkinson’s Disease OFF Episodes
Sunovion Pharmaceuticals Inc. announced that Health Canada has approved KYNMOBI soluble film for the acute, intermittent treatment of OFF episodes in patients with Parkinson’s disease (PD). OFF episodes are the re-emergence or worsening of PD symptoms otherwise controlled with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.